IAIM
PTCT icon

International Assets Investment Management’s PTC Therapeutics PTCT Stock Holding History

International Assets Investment Management’s Portfolio PTCT Stock Details PTCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.79K Buy
22
+4
+22% +$289 ﹤0.01% 2134
2026
Q1 		$1.24K Buy
18
+2
+13% +$142 ﹤0.01% 2037
2025
Q4 		$1.22K Buy
+16
New +$1.16K ﹤0.01% 2016
2024
Q4 		– Sell
-16
Closed -$594 – 1621
2024
Q3 		$594 Hold
16
– – ﹤0.01% 1763
2024
Q2 		$489 Buy
+16
New +$518 ﹤0.01% 2174
2023
Q2 		– Sell
-16
Closed -$775 – 778
2023
Q1 		$775 Buy
+16
New +$731 ﹤0.01% 1060

Other funds holding PTCT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Toronto Dominion Bank
Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $86.4B AUM 59.51% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return

International Assets Investment Management's PTCT Position: Q2 2026 in Review

International Assets Investment Management increased its PTC Therapeutics (PTCT) stake by 22% in Q2 2026, buying an estimated $289 and bringing the position to 22 shares worth $1.79K. The position accounts for ﹤0.01% of the portfolio, ranked #2134.

International Assets Investment Management first reported a position in PTCT in Q1 2023 and has held it in 6 quarters since. 382 funds tracked by Wall St. Rank hold PTCT as of Q2 2026.

  • International Assets Investment Management held 22 shares of PTC Therapeutics worth $1.79K as of Q2 2026.
  • International Assets Investment Management bought 4 PTC Therapeutics shares in Q2 2026, an estimated $289.
  • PTC Therapeutics made up ﹤0.01% of International Assets Investment Management's portfolio in Q2 2026, its #2134 holding.
  • International Assets Investment Management first reported a position in PTC Therapeutics in Q1 2023 and has held it in 6 quarters since.
  • 382 funds tracked by Wall St. Rank held PTC Therapeutics as of Q2 2026.

Based on International Assets Investment Management's 13F filing for Q2 2026, filed 22 Jul 2026.